A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion

NCT00626600 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

33

Enrollment

INDUSTRY

Sponsor class

Stopped Lack of recruitment

Conditions

Severe Caner Pain

Interventions

DRUG: Oxycodone Hydrochloride

Sponsor

Mundipharma Research Limited